Clinical Trial Update: Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead

View source ↗

Summary

The Abbott Medical Devices-sponsored trial evaluating multi-site left ventricular pacing with the Quartet 1458Q lead has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Multi-site Left Ventricular Pacing | Status: COMPLETED